1,324
Views
4
CrossRef citations to date
0
Altmetric
Editorial

Determining the cost–effectiveness of adult pneumococcal vaccination strategies

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

A. T. Newall. (2016) What do we know about the cost-effectiveness of pneumococcal conjugate vaccination in older adults?. Human Vaccines & Immunotherapeutics 12:10, pages 2666-2669.
Read now
Rosalind Hollingsworth & Raul Isturiz. (2014) The stubborn persistence of adult pneumococcal pneumonia as a public health problem. Human Vaccines & Immunotherapeutics 10:5, pages 1319-1321.
Read now

Articles from other publishers (2)

Livio Garattini, Anna Padula & Milene Rangel Da Costa. (2015) Economic Evidence of Pneumococcal Vaccination in Older Adults: Uncertain Modelling or Competitive Tendering?. PharmacoEconomics 34:3, pages 221-224.
Crossref
Marie-Josée J. Mangen, Mark H. Rozenbaum, Susanne M. Huijts, Cornelis H. van Werkhoven, Douwe F. Postma, Mark Atwood, Anna M.M. van Deursen, Arie van der Ende, Diederick E. Grobbee, Elisabeth A.M. Sanders, Reiko Sato, Theo J.M. Verheij, Conrad E. Vissink, Marc J.M. Bonten & G. Ardine de Wit. (2015) Cost-effectiveness of adult pneumococcal conjugate vaccination in the Netherlands. European Respiratory Journal 46:5, pages 1407-1416.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.